Marino C, Foster J
J Vet Intern Med. 2024; 38(4):2344-2347.
PMID: 38695414
PMC: 11256122.
DOI: 10.1111/jvim.17098.
Nagami G, Kraut J
Int J Mol Sci. 2024; 25(4).
PMID: 38397097
PMC: 10889389.
DOI: 10.3390/ijms25042420.
Jo S
Electrolyte Blood Press. 2023; 21(1):24-33.
PMID: 37434804
PMC: 10329905.
DOI: 10.5049/EBP.2023.21.1.24.
Chiu C, Hsuan C, Lin S, Hung Y, Hwu C, Hee S
J Biomed Sci. 2023; 30(1):13.
PMID: 36803854
PMC: 9940419.
DOI: 10.1186/s12929-023-00905-7.
Abdelaal Ahmed Mahmoud A, Campbell M, Blajeva M
Case Rep Anesthesiol. 2018; 2018:1852016.
PMID: 30112218
PMC: 6077600.
DOI: 10.1155/2018/1852016.
Hyperkalemia in the Hypertensive Patient.
Lakkis J, Weir M
Curr Cardiol Rep. 2018; 20(2):12.
PMID: 29492706
DOI: 10.1007/s11886-018-0954-2.
Changes in urinary potassium excretion in patients with chronic kidney disease.
Ueda Y, Ookawara S, Ito K, Miyazawa H, Kaku Y, Hoshino T
Kidney Res Clin Pract. 2016; 35(2):78-83.
PMID: 27366661
PMC: 4919657.
DOI: 10.1016/j.krcp.2016.02.001.
Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management.
Sousa A, Cabral J, El-Feghaly W, de Sousa L, Nunes A
World J Diabetes. 2016; 7(5):101-11.
PMID: 26981183
PMC: 4781902.
DOI: 10.4239/wjd.v7.i5.101.
Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.
Mule G, Nardi E, Guarino L, Cacciatore V, Geraci G, Calcaterra I
Hypertens Res. 2015; 38(4):276-83.
PMID: 25567771
DOI: 10.1038/hr.2014.171.
Treatment of metabolic acidosis in patients with CKD.
Chen W, Abramowitz M
Am J Kidney Dis. 2013; 63(2):311-7.
PMID: 23932089
PMC: 3946919.
DOI: 10.1053/j.ajkd.2013.06.017.
A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
Goraya N, Simoni J, Jo C, Wesson D
Clin J Am Soc Nephrol. 2013; 8(3):371-81.
PMID: 23393104
PMC: 3586961.
DOI: 10.2215/CJN.02430312.
Pathogenesis, diagnosis and management of hyperkalemia.
Lehnhardt A, Kemper M
Pediatr Nephrol. 2010; 26(3):377-84.
PMID: 21181208
PMC: 3061004.
DOI: 10.1007/s00467-010-1699-3.
Consequences and therapy of the metabolic acidosis of chronic kidney disease.
Kraut J, Madias N
Pediatr Nephrol. 2010; 26(1):19-28.
PMID: 20526632
PMC: 2991191.
DOI: 10.1007/s00467-010-1564-4.
Safety of perioperative hemodialysis and continuous hemodiafiltration for dialysis patients with cardiac surgery.
Kamohara K, Yoshikai M, Yunoki J, Fumoto H, Murayama J, Hamada M
Gen Thorac Cardiovasc Surg. 2007; 55(2):43-9.
PMID: 17444174
DOI: 10.1007/s11748-006-0072-8.
Reversible impairment of renal function associated with enalapril in a diabetic patient.
Albareda M, Corcoy R
CMAJ. 1998; 159(10):1279-81.
PMID: 9861226
PMC: 1229824.
A Bedouin kindred with infantile nephronophthisis demonstrates linkage to chromosome 9 by homozygosity mapping.
Haider N, Carmi R, Shalev H, Sheffield V, Landau D
Am J Hum Genet. 1998; 63(5):1404-10.
PMID: 9792867
PMC: 1377550.
DOI: 10.1086/302108.
ACE inhibitors and the kidney. A risk-benefit assessment.
Navis G, Faber H, de Zeeuw D, de Jong P
Drug Saf. 1996; 15(3):200-11.
PMID: 8879974
DOI: 10.2165/00002018-199615030-00005.
Hyporeninemic hypoaldosteronism complicating primary autonomic insufficiency.
Polsky F, Roque D, Hill P
West J Med. 1993; 159(2):185-7.
PMID: 8212689
PMC: 1022230.
OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure.
Zwettler U, Fliser D, Nowicki M, Ritz E
Eur J Clin Pharmacol. 1994; 46(3):185-9.
PMID: 8070497
DOI: 10.1007/BF00192546.
Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.
Kirby B, Ham J, Fairley H, Benowitz N, Schambelan M
West J Med. 1983; 139(2):221-5.
PMID: 6636736
PMC: 1010945.